Clinical Trial Update: Kinematic-guided BoNT-A Treatment for ET and PD Tremor [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on kinematic-guided botulinum toxin A treatment for tremor in essential tremor and Parkinsonian tremor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tremor

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Western University, Canada | Conditions: Tremor | Phase 2 | Status: UNKNOWN | Results posted: 2019-08-20